R&D The Alderley Park Discovery Podcast: COVID testing and the L... Alderley Park’s Mereside campus is at the forefront of the UK’s COVID-19 testing plans, playing a key role in the national Lighthouse Lab programme.
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.